Shandong Duanxintang Dayu Pharmaceutical Co., Ltd.
Main products:Rutin,Quercetin
Contact Us
  • Contact Person : Ms. Zhu Jean
  • Company Name : Shandong Duanxintang Dayu Pharmaceutical Co., Ltd.
  • Tel : 86-537-3422110
  • Fax : 86-537-3412369
  • Address : Shandong,Yanzhou,No. 1, Tiebei East Street
  • Country/Region : China
  • Zip : 272100

Hot sale GMP certificate Troxerutin CAS NO 7085-55-4

Hot sale GMP certificate Troxerutin CAS NO 7085-55-4
Product Detailed
1)Assay :95.0% - 102.0% 2)CAS NO.: 7085-55-4 3)GMP certificate 4)100% nature 5)Standard: EP 5.3 EP6

Name: Troxerutin

Assay :95.0% - 102.0%Export to Asia, USA and Europe

CAS NO.: 7085-55-4Molecular Formula: C33H42O19

Molecular Weight: 742.68

Standard: EP 5.3/EP6/DAB1999

Chemical name : 2-[3,4-Bis(2-hydroxyethoxy)phenyl]-5-hydroxy-7-(2-hydroxy-ethoxy)-3-(6-O-a-L-rhamnopyranosyl-b-D-glucopyranosyloxy)-4H-chromen-4-on

Other names:

7,3',4'-Tris[O-(2-hydroxyethyl)] rutin; trioxyethylrutin; tri(hydroxyethyl) rutoside

Physical form: Yellowish green powder

Melting point:168~176°C

M. F. & M. W. : C33H42O19

Assay:95.0% - 102.0%

Particle size: 100% pass through 80 mesh

Main peak: ≥80.0%

One peak:≤10.00%

Single peak: ≤5.0%

Ethylene oxide:≤1ppm

Heavy metals: ≤10.0ppm

Loss on drying:≤5.0%

Storage: avoid light, closeness, keep at the cool, dry place

Valid: 24monthes


This product can inhibit platelet aggregation, prevent thrombosis, can cure the vascular injury induced by 5 serotonin or bradykinin, increase the capillary resistance, reduce the capillary permeability, prevent edema caused by the increasement of vascular permeability. It has the significant protective effect to acute ischemic brain injury. Applying

As the treatment of cerebral thrombosis or the sequela due from the cerebral embolism, such as the hemiplegia, aphasia and myocardial infarction syndrome, arteriosclerosis, central retinitis, phlebitis of thrombosis, varicose veins, edema caused by the vascular permeability rising.



Hot sale GMP certificate Troxerutin CAS NO 7085-55-4

Copyright Notice @ 2008-2012 ECVERY Limited and/or its subsidiaries and licensors. All rights reserved.